These effects might be mediated through the modulation of key pathogenic molecules in PAH, notably IL‐6 and TGF‐β1 [29, 30], thereby linking the immune‐driven injury to the structural remodeling in IPAH. This evidence concerns the gene IL6 and pulmonary arterial hypertension.